Cambridge Uni Aims For Autumn Trials Of Coronavirus Vaccine (RTRS)

The University of Cambridge is aiming to start clinical trials of its possible coronavirus vaccine in the autumn after it received 1.9 million pounds in funding from the British government, the university said on Wednesday. The scientists behind the vaccine said their approach, which uses genetic sequences of all known coronaviruses to hone the immune response, could help avoid the adverse effects of a hyper-inflammatory immune response. "We're looking for chinks in its armour, crucial pieces of the virus that we can use to construct the vaccine to direct the immune response in the right direction," Jonathan Heeney, head of the Laboratory of Viral Zoonotics at the University of Cambridge, said.

• Click here for story.